Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
Monsanto's seed and genomics segment net sales 2011-2017
This statistic depicts agrochemical company Monsanto's net sales in the seed and genomics segment from 2011 to 2017, by specialty. In 2017, the corn seed and traits specialty came to approximately 6.27 billion U.S. dollars of net sales. Monsanto was an agricultural company specialized on genetically engineered seeds. The company was headquartered in St Louis, Missouri. In September 2016, Bayer finalized a deal to take Monsanto over, which was completed on June 7, 2018.

Monsanto

Monsanto was engaged in the agribusiness industry and a global leader in biotechnology. The agricultural products company was headquartered in St. Louis, Missouri and employed about 20,500 regular employees as of August 2017. Monsanto’s product portfolio contained agricultural seeds and genomics, traits and technologies, and crop protection solutions. The seeds segment included herbicide-, insect- and drought-tolerant seeds. The company provided genetically modified crops (GM crops), or in countries where the modification of plants is not adopted, Monsanto sold conventional, non-GM plants. Monsanto’s most prominent example of genetically engineered crops was ‘Roundup Ready’ soybeans and corn.

Monsanto’s specialization in genetically engineered crops was long - and still is - a topic with intense debate and has sparked a lot of controversy over the years. Thus, the planting of GM crops is allowed in the United States and Canada, but several specific crops were banned in other countries such as Germany and France. Opponents of the implementation of genetically modified crops fear that altering the genetic genome may bring unknown consequences and that it has been not researched well enough.
Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
Corn seed and traitsSoybean seed and traitsVegetable seedsCotton seed and traits
20176,2702,662815615
20165,8252,162801440
20155,9532,276816523
20146,4012,102867665
20136,5961,653821695
20125,8141,771851779
20114,8051,542895847
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2017

Region

Worldwide

Survey time period

2011 to 2017

Supplementary notes

* Fiscal years ending on August 31.
Values prior to 2015 were added from previous annual reports.

Open this statistic in...
Monsanto's seed and genomics segment net sales 2011-2017
This statistic depicts agrochemical company Monsanto's net sales in the seed and genomics segment from 2011 to 2017, by specialty. In 2017, the corn seed and traits specialty came to approximately 6.27 billion U.S. dollars of net sales. Monsanto was an agricultural company specialized on genetically engineered seeds. The company was headquartered in St Louis, Missouri. In September 2016, Bayer finalized a deal to take Monsanto over, which was completed on June 7, 2018.

Monsanto

Monsanto was engaged in the agribusiness industry and a global leader in biotechnology. The agricultural products company was headquartered in St. Louis, Missouri and employed about 20,500 regular employees as of August 2017. Monsanto’s product portfolio contained agricultural seeds and genomics, traits and technologies, and crop protection solutions. The seeds segment included herbicide-, insect- and drought-tolerant seeds. The company provided genetically modified crops (GM crops), or in countries where the modification of plants is not adopted, Monsanto sold conventional, non-GM plants. Monsanto’s most prominent example of genetically engineered crops was ‘Roundup Ready’ soybeans and corn.

Monsanto’s specialization in genetically engineered crops was long - and still is - a topic with intense debate and has sparked a lot of controversy over the years. Thus, the planting of GM crops is allowed in the United States and Canada, but several specific crops were banned in other countries such as Germany and France. Opponents of the implementation of genetically modified crops fear that altering the genetic genome may bring unknown consequences and that it has been not researched well enough.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Monsanto-Bayer"
  • Overview
  • Financial Data
  • Agricultural Products
  • Pharmaceuticals
  • Monsanto
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.